comparison consist prior organ guid
much favor prior expect though
organ strong throughout octob order remain apac septemb
favor top guidanc order inclus china
continu eas except growth includ time invest alloc
sector segment ebit rose vs estim rose
year fund dividends/repurchas acquisit
end net debt/ebitda
core ep discret tax benefit match in-
revenu grew y-o-i organ net a/d fx vs
estim segment om decreas bp rose bp excl
recent deal vs estim
set ep guidanc vs prior consensu
revenu organ acqui fx autom
solut organ expect report rs
report outlook set
solut sale rose organ vs guid match
estim om bp bp excl avent vs
estim grew organ report vs estimate-includ
organ guid om bp bp excl tool
test vs estim
guid vs prior consensu
top line organ acqui fx reflect soft season
quarter baselin continu invest execut solid autom
growth outlook softer china patch still lag price/cost
recoveri neutral
lower ep
perform rate reflect potenti conservat respect healthi
price-to-earnings multipl note model fcf/ni view roughli
emerson global technolog
commerci residenti market
analyst certif import disclosur see disclosur
complet portfolio move pave way core portfolio leverag
long-term autom solut runway draw integration/
order recoveri tradit outpac process market
acceler sustain rejuven cyclic end market china
capit deploy process climat segment drive strong
see emerg inflect driver built expect
least partial path earn power visibl clear
think share bake best-cas cyclic rebound
scenario one appropri balanc discount
reason estim rang report ep favor
innat normal earn power loom increasingli
attract share price support look convict
acceler oper leverag volum recoveri autom
integr recent portfolio move prove choppi
slower cyclic recoveri depress end market
exhibit segment result varianc opco estim
net incom cont op
ep cont op
incom disc op
report core ep discret tax benefit includ
contribut transact relat item y-o-i match in-lin estim
vs guidanc guidanc includ acquisit charg one-tim
contribut net revenu increas y-o-i core net a/d fx vs
asia china east/africa
report cfo vs ly capital-expenditure vs ly
result spent dividend share repurchas
along acquisit manag target share repurchas
guidanc establish ep guidanc vs prior consensu
manag expect report revenu y-o-i core sale acquisit
fx autom solut revenu expect core sale
commerci residenti solut report sale expect core sale
set cfo guidanc capital-expenditure result guidanc
expect ep revenu report core lower y-o-i
ebit margin due acquisit dilut
solut revenu sale grew y-o-i core acq
fx match estim geograph north america grew asia china europ
latin america me/a margin increas bp y-o-i bp
exclud avent volum leverag restructur benefit favor mix
commerci residenti solut revenu revenu y-o-i
core acquisit fx vs estim geograph north america grew asia
china europ latin america me/a margin decreas bp y-o-
estim reflect volum leverag improv price/cost partial
off-set materi inflat bp exclud tool test
compani report oppenheim co inc
annual sale profit segment
adjust ebt
differ account method
adjust ebit
adjust net incom
net incom cont op
dilut ep cont op
quarterli sale profit segment
adjust ebt
differ account method
adjust ebit
adjust net incom
net incom cont op
net incom cont op
dilut ep cont op
analysi oper
segment revenu
total segment revenu
segment profit
total segment profit
year end sepemb million
good sold
amort intang
ration oper
net incom cont op
net incom extraordinari
dilut ep continu oper
sale
amort intang
ration oper
net incom cont op
net incom cont op
dilut ep cont op
year end septemb million
average day inventori day hand
consolid statement flow
year end septemb million
depreci pp
net chang work capit
disc op
flow oper
sale properti invest
disc op
chang current debt
chang long-term debt
chang capit stock
increas dec
equival -b
equival -e
